Meet our SPARK Fellows

Introducing Cohort 8

Karin Payne Image

Karin Payne, PhD

A Regenerative Biomaterial Therapeutic to Treat Osteoarthritis

A Regenerative Biomaterial Therapeutic to Treat Osteoarthritis

Osteoarthritis (OA) affects millions globally, causing pain, stiffness, and disability, with significant economic costs. Current treatments focus on pain management, lacking curative options. We are developing novel biomaterials that mimic cartilage and bone to support regeneration, aiming to reverse OA through minimally invasive arthroscopic therapy. Our project will help define the target product profile, pre-clinical studies for FDA approval, and develop an insurance reimbursement strategy.

Learn more about Dr. Payne

Cohort 7

Jessica Rove, MD

Jessica Rove, MD

Colorado Chest Tube

Juan-Pablo Idrovo, MD

Juan-Pablo Idrovo, MD

Gastrostomy Tube Guardian

Rui Zhao, PhD

Rui Zhao, PhD

Developing a First-in-Class Allosteric Eya2 Tyrosine Phosphatase Inhibitor for Brain Cancer Therapy

Sujatha Venkataraman, PhD

Development of Gated Dual-antigen Targeting CAR-T Cell Therapy to Treat ATRT, an Aggressive Brain Tumor in Children

zhirui_wang_500

Zhirui Wang, PhD

Bivalent CD47 Immunotoxin for Targeted Therapy of T-Cell Acute Lymphoblastic Leukemia and Other CD47+ Cancers

Cohort 6

Karin Payne Image

Karin Payne, PhD

A Regenerative Biomaterial Therapeutic to Treat Osteoarthritis

A Regenerative Biomaterial Therapeutic to Treat Osteoarthritis

Osteoarthritis (OA) affects millions globally, causing pain, stiffness, and disability, with significant economic costs. Current treatments focus on pain management, lacking curative options. We are developing novel biomaterials that mimic cartilage and bone to support regeneration, aiming to reverse OA through minimally invasive arthroscopic therapy. Our project will help define the target product profile, pre-clinical studies for FDA approval, and develop an insurance reimbursement strategy.

Learn more about Dr. Payne

Cohort 5

Karin Payne Image

Karin Payne, PhD

A Regenerative Biomaterial Therapeutic to Treat Osteoarthritis

A Regenerative Biomaterial Therapeutic to Treat Osteoarthritis

Osteoarthritis (OA) affects millions globally, causing pain, stiffness, and disability, with significant economic costs. Current treatments focus on pain management, lacking curative options. We are developing novel biomaterials that mimic cartilage and bone to support regeneration, aiming to reverse OA through minimally invasive arthroscopic therapy. Our project will help define the target product profile, pre-clinical studies for FDA approval, and develop an insurance reimbursement strategy.

Learn more about Dr. Payne

Cohort 4

Cohort 3

Cohort 2

Cohort 1

CU Innovations

CU Anschutz

Anschutz Health Sciences Building

1890 N Revere Ct

Suite 6202

Mail Stop F411

Aurora, CO 80045


303-724-3720

CMS Login